Clinical pattern of primary systemic therapy and outcomes of estrogen receptor-positive, HER2-negative metastatic breast cancer: a review of a single institution
ConclusionOur findings suggest the possibility for changing the treatment paradigm of patients with ER+HER2 −MBC, so a randomized prospective study is warranted to determine the optimum sequence of systemic therapies.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Endocrine Therapy | HER2 | Liver | Study | Urology & Nephrology